Divi's Laboratories Limited

LIC decreased its stake in Divi's Laboratories Limited from 2.79% to 2.53%, selling 7,05,735 shares for ₹600.27 crore at ₹8496.00 apiece.

A leading manufacturer and exporter of active pharmaceutical ingredients, intermediates, and nutraceutical ingredients serving global pharmaceutical and healthcare markets. Incorporated in 1990, the company operates across multiple therapeutic segments with vertically integrated manufacturing infrastructure. It distinguishes itself through expertise in complex chemistry, stringent quality standards, and a diversified product portfolio catering to customers worldwide.

India's largest domestic institutional investor with over Rs 56 lakh crore in total AUM, of which roughly Rs 15 lakh crore sits in listed equities. Holds stakes in virtually every major listed Indian company. When LIC builds or exits a position, it moves markets. Government-owned and mandated to invest policyholder funds in Indian equities and bonds, making it the ultimate long-only, long-term India bull.